Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912308609> ?p ?o ?g. }
Showing items 1 to 76 of
76
with 100 items per page.
- W2912308609 endingPage "19" @default.
- W2912308609 startingPage "19" @default.
- W2912308609 abstract "Background: We have recently reported that primary and secondary immunodeficiency patients have different perspectives on the clinical and quality of life impact of immunoglobulin therapy (unpublished data). Purpose: This study compares the clinical efficacy of the first against the second year of home‐based subcutaneous immunoglobulin (SCIG) treatment option in patients with common variable immunodeficiency (CVID). Methods: Retrospective data was collected on the first two years of SCIG treatment in 21 CVID patients at the Sunshine Coast Hospital and Health Services. Results: The mean age of the cohort was 48.2 years (range 23‐84) and included 9 females and 12 males. Three patients had bronchiectasis and one patient had chronic obstructive pulmonary disease from beginning of study period, two developed bronchiectasis during study period. SCIG dosage ranged from 3.2 to 13.6 g/week, with mean cohort (n=21) dose of 8.6g/week in the first year and 8.3g/week in the second year. Over two years, the dose of three patients was increased and for another three was decreased. The mean serum IgG trough level (n=18) was 9.19 g/L in the first year and 9.24 in the second year. The mean annual infection rate (n=18) was 2.00 in the first year and 1.44 in the second. Total number of infections in year one was 31 episodes with 22 respiratory infections, and in year two it was 25 episodes with 13 respiratory infections. At the end of the second year on SCIg one patient died and one patient was returned to intravenous immunoglobulin due to compliance issues. Conclusion: Overall, there was no statistical difference in dosage, serum IgG trough levels and annual infection rate between first and second year on SCIG. This indicates that SCIG is an effective treatment mode for minimising the risk of recurrent infection in patients with CVID in Australia." @default.
- W2912308609 created "2019-02-21" @default.
- W2912308609 creator A5038713722 @default.
- W2912308609 creator A5059740962 @default.
- W2912308609 creator A5073081611 @default.
- W2912308609 creator A5079905005 @default.
- W2912308609 creator A5085150777 @default.
- W2912308609 date "2018-05-01" @default.
- W2912308609 modified "2023-09-28" @default.
- W2912308609 title "Subcutaneous immunoglobulin in patients with common variable immunodeficiency" @default.
- W2912308609 hasPublicationYear "2018" @default.
- W2912308609 type Work @default.
- W2912308609 sameAs 2912308609 @default.
- W2912308609 citedByCount "0" @default.
- W2912308609 crossrefType "journal-article" @default.
- W2912308609 hasAuthorship W2912308609A5038713722 @default.
- W2912308609 hasAuthorship W2912308609A5059740962 @default.
- W2912308609 hasAuthorship W2912308609A5073081611 @default.
- W2912308609 hasAuthorship W2912308609A5079905005 @default.
- W2912308609 hasAuthorship W2912308609A5085150777 @default.
- W2912308609 hasConcept C126322002 @default.
- W2912308609 hasConcept C141071460 @default.
- W2912308609 hasConcept C159654299 @default.
- W2912308609 hasConcept C167135981 @default.
- W2912308609 hasConcept C187212893 @default.
- W2912308609 hasConcept C203014093 @default.
- W2912308609 hasConcept C2776433325 @default.
- W2912308609 hasConcept C2777714996 @default.
- W2912308609 hasConcept C2779019163 @default.
- W2912308609 hasConcept C2779134260 @default.
- W2912308609 hasConcept C2779379686 @default.
- W2912308609 hasConcept C71924100 @default.
- W2912308609 hasConcept C72563966 @default.
- W2912308609 hasConceptScore W2912308609C126322002 @default.
- W2912308609 hasConceptScore W2912308609C141071460 @default.
- W2912308609 hasConceptScore W2912308609C159654299 @default.
- W2912308609 hasConceptScore W2912308609C167135981 @default.
- W2912308609 hasConceptScore W2912308609C187212893 @default.
- W2912308609 hasConceptScore W2912308609C203014093 @default.
- W2912308609 hasConceptScore W2912308609C2776433325 @default.
- W2912308609 hasConceptScore W2912308609C2777714996 @default.
- W2912308609 hasConceptScore W2912308609C2779019163 @default.
- W2912308609 hasConceptScore W2912308609C2779134260 @default.
- W2912308609 hasConceptScore W2912308609C2779379686 @default.
- W2912308609 hasConceptScore W2912308609C71924100 @default.
- W2912308609 hasConceptScore W2912308609C72563966 @default.
- W2912308609 hasLocation W29123086091 @default.
- W2912308609 hasOpenAccess W2912308609 @default.
- W2912308609 hasPrimaryLocation W29123086091 @default.
- W2912308609 hasRelatedWork W1982929186 @default.
- W2912308609 hasRelatedWork W2053769124 @default.
- W2912308609 hasRelatedWork W2120971363 @default.
- W2912308609 hasRelatedWork W2136572280 @default.
- W2912308609 hasRelatedWork W2241164495 @default.
- W2912308609 hasRelatedWork W2357058107 @default.
- W2912308609 hasRelatedWork W2418021641 @default.
- W2912308609 hasRelatedWork W2602653409 @default.
- W2912308609 hasRelatedWork W2613164134 @default.
- W2912308609 hasRelatedWork W3009061734 @default.
- W2912308609 hasRelatedWork W3044580679 @default.
- W2912308609 hasRelatedWork W3097274327 @default.
- W2912308609 hasRelatedWork W3158150417 @default.
- W2912308609 hasRelatedWork W3166398601 @default.
- W2912308609 hasRelatedWork W3169704482 @default.
- W2912308609 hasRelatedWork W3184659669 @default.
- W2912308609 hasRelatedWork W3196516217 @default.
- W2912308609 hasRelatedWork W3213240958 @default.
- W2912308609 hasRelatedWork W88610012 @default.
- W2912308609 hasRelatedWork W3195553569 @default.
- W2912308609 hasVolume "48" @default.
- W2912308609 isParatext "false" @default.
- W2912308609 isRetracted "false" @default.
- W2912308609 magId "2912308609" @default.
- W2912308609 workType "article" @default.